Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL
/in Dendritic Cells, International PublicationsHarnessing dendritic cells to generate cancer vaccines
/in Dendritic Cells, International PublicationsCombining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers
/in Dendritic Cells, International PublicationsBrain tumor immunotherapy with type-1 polarizing strategies
/in Glioblastoma, International PublicationsMassive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
/in Dendritic Cells, Hypernephroma, International PublicationsImmunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
/in Dendritic Cells, Hyperthermia, International PublicationsPolarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusTumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo
/in Colorectal Cancer, Dendritic Cells, International PublicationsAntigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer